PN Medical and Orbita have formed a partnership to use Orbita’s digital platform with its own products to enable clinicians to better monitor and support patients with COPD.
PN Medical and Orbita announced they have formed a partnership to leverage Orbita’s next-generation digital platform with its own products, designed to enable clinicians to better monitor and support patients with chronic conditions like chronic obstructive pulmonary disease (COPD), hypertension, and congestive heart failure.
“In 1980, we were first to market with The Breather, our revolutionary respiratory device. Now, thanks to our partnership with Orbita, we’re leading the way again in transforming healthcare at home,” Mark A. Carbone, PN Medical’s chief executive officer, said in a press release. Orbita, he added, is “the only technology provider that met all of our requirements for creating this smart, connected care application.”
Orbita’s platform gathers data from wearables, home-health devices, and other connected devices into a collaborative care experiences to improve patient engagement and care coordination.
PN Medical also announced that it has updated its home-care product, launching ‘The Breather+, a respiratory muscle training (RMT) device that relies on Bluetooth technology, and works as a diagnostic to measure lung capacity while improving breathing function through therapeutic inhaling and exhaling exercises. Data is relayed to the Orbita-powered practitioner dashboard via the Breather+ mobile app, allowing for real-time monitoring and managing of patients.